FPT Digital Retail Joint Stock Company (FRT) Q2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2023 earnings summary
3 Nov, 2026Executive summary
H1 2023 revenue rose to VND 14.924tn from VND 13.999tn YoY, while operating profit swung to a VND 204.1bn loss from VND 258.1bn profit.
H1 consolidated net loss was VND 212.7bn; loss attributable to the parent was VND 223.7bn, with basic EPS of VND -1,642.
Financial highlights
Net revenue increased to VND 14.924tn from VND 13.999tn YoY; gross profit rose to VND 2.268tn from VND 2.176tn.
Cost of sales increased to VND 12.656tn from VND 11.823tn; selling expenses were VND 1.874tn and general and administration expenses were VND 461.5bn.
Financial income fell to VND 26.0bn from VND 94.5bn, while financial expenses increased to VND 162.6bn from VND 115.3bn.
Profit before tax was a VND 198.3bn loss versus VND 263.0bn profit YoY; consolidated net loss was VND 212.7bn versus net profit of VND 216.1bn.
Segment performance
Operations comprise informatics equipment, mobile phones, components and related accessories, and pharmaceutical business.
The pharmaceutical subsidiary is 89.83%-owned; operations are conducted in Vietnam, with branches across 63 provinces and cities.
Latest events from FPT Digital Retail Joint Stock Company
- Parent-attributable loss and negative operating cash flow marked a weak Q1 despite VND 7.753tn revenue.FRT
Q1 2023 - Revenue grew, but 9M 2023 ended in a VND 225.704bn net loss.FRT
Q3 2023 - Revenue increased, but FY2023 ended with a VND 329.2bn net loss and heavy operating cash outflow.FRT
Q4 2023 - Gross profit and operating cash flow improved as revenue fell and losses narrowed.FRT
Q1 2024 - 9M revenue rose and earnings returned to profit, with operating cash flow at VND 1.74T.FRT
Q3 2024 - H1 revenue advanced, earnings returned to profit, and operating cash flow strengthened.FRT
Q2 2024 - FY2024 returned to profit despite lower revenue, with year-end cash rising to VND 1.170tn.FRT
Q4 2024 - Q1 net profit reached VND 212.8bn as revenue climbed to VND 11.67tn.FRT
Q1 2025 - H1 profit more than tripled as revenue advanced and pharmaceutical operations led segment results.FRT
Q2 2025